RecruitingAccepts healthy volunteers
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Washington University School of Medicine · NCT07109427
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–75 · Men only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40000
- US sites recruiting
- 1
- Study start
- August 11, 2025
- Record last updated
- August 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care:
- Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines.
- Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices.
- The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.
Being studied: Annual PSA Health Maintenance Reminder
Conditions: Prostate Cancer; Cancer of the Prostate
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Eligibility Criteria
- Receive care within the BJC Health System
- Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care)
- Be male
- Not have a history of prostate cancer
- Meet one of the following risk criteria:
- High Risk for Prostate Cancer
- African American, between the ages of 40 and 75 (inclusive), or
- Family history of prostate, breast, ovarian, and/or pancreatic cancer, or
- Known familial germline mutation OR
- Average Risk for Prostate Cancer
- Between the ages of 50 and 75 (inclusive)
Recruiting US locations
Washington University School of Medicine
St Louis, MO 63110
Site contact: Lannis Hall, M.D., MPH · 636-916-9947 · lannishall@wustl.edu
Study contacts (from the official record)
- Lannis Hall, M.D., MPH · 636-916-9947 · lannishall@wustl.edu
Similar studies in Missouri
All healthy volunteers studies in Missouri →- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 2 mo–1